Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor
Links shared publicly online about this topic.
- 1,728total visits
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor
Vitae pharmaceuticals, inc., an integrated discovery and development company, announced that it has initiated a phase 1 clinical trial of its novel cardiovascular agent, vtp-27999. vtp-27
View full resource at medicalnewstoday.com
Tags: Pharma, Phase 1 Clinical Trial, Clinical Trial
Most Recently Shared on September 23, 2009 at 11:20 am By:
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor: Vitae Pharmaceuticals, Inc., an integrated discovery and.. http://bit.ly/Q0WpL
Advertisement
